{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T09:40:59Z","timestamp":1747993259445},"reference-count":19,"publisher":"Japanese Society of Internal Medicine","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.2169\/internalmedicine.6413-20","type":"journal-article","created":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T22:06:23Z","timestamp":1618178783000},"page":"3125-3128","source":"Crossref","is-referenced-by-count":3,"title":["Spontaneous Remission of Thrombospondin Type-1 Domain-Containing-Associated Membranous Nephropathy"],"prefix":"10.2169","volume":"60","author":[{"given":"Shiika","family":"Watanabe","sequence":"first","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Japan"},{"name":"Department of Nephrology, Kameda Medical Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Nakata","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Koitabashi","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ichikawa","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Kamijo-Ikemori","sequence":"additional","affiliation":[{"name":"Department of Anatomy, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junki","family":"Koike","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugo","family":"Shibagaki","sequence":"additional","affiliation":[{"name":"Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Couser WG. Primary membranous nephropathy. Clin J Am Soc Nephrol 12: 983-997, 2017.","DOI":"10.2215\/CJN.11761116"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Ponticelli C, Glassock RJ. Glomerular diseases: membranous nephropathy--a modern view. Clin J Am Soc Nephrol 9: 609-616, 2014.","DOI":"10.2215\/CJN.04160413"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Polanco N, Guti\u00e9rrez E, Covars\u00ed A, et al. Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy. J Am Soc Nephrol 21: 697-704, 2010.","DOI":"10.1681\/ASN.2009080861"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Hofstra JM, Debiec H, Short CD, et al. Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 23: 1735-1743, 2012.","DOI":"10.1681\/ASN.2012030242"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Iwakura T, Ohashi N, Kato A, Baba S, Yasuda H. Prevalence of enhanced granular expression of thrombospondin type-1 domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy. PLoS One 10: e0138841, 2015.","DOI":"10.1371\/journal.pone.0138841"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Hoxha E, Wiech T, Stahl PR, et al. A mechanism for cancer-associated membranous nephropathy. N Engl J Med 374: 1995-1996, 2016.","DOI":"10.1056\/NEJMc1511702"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Wang J, Cui Z, Lu J, et al. Circulating antibodies against thrombospondin type-I domain-containing 7A in Chinese patients with idiopathic membranous nephropathy. Clin J Am Soc Nephrol 12: 1642-1651, 2017.","DOI":"10.2215\/CJN.01460217"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Matsumoto A, Matsui I, Namba T, et al. VEGF-A links angiolymphoid hyperplasia with eosinophilia (ALHE) to THSD7A membranous nephropathy: a report of 2 cases. Am J Kidney Dis 73: 880-885, 2019.","DOI":"10.1053\/j.ajkd.2018.10.009"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Hara S, Tsuji T, Fukasawa Y, et al. Clinicopathological characteristics of thrombospondin type 1 domain-containing 7A-associated membranous nephropathy. Virchows Archiv 474: 735-743, 2019.","DOI":"10.1007\/s00428-019-02558-0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Shirai S, Akiyama S, Kamijo-Ikemori A, et al. Membranous nephropathy associated with thrombospondin type-1 domain-containing 7A (THSD7A) in an adult woman with eosinophilia. CEN Case Rep 9: 65-73, 2020.","DOI":"10.1007\/s13730-019-00430-3"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Suzuki T, Ushimaru S, Uchida D, et al. Refractory THSD7A membranous nephropathy with severe asthma related to eosinophilia. Clin Nephrol 92: 103-108, 2019.","DOI":"10.5414\/CN109751"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Suzuki T, Han W, Watanabe S, et al. Clinical characteristics of thrombospondin type-1 domain-containing 7A-associated membranous nephropathy. Ren Fail 42: 966-968, 2020.","DOI":"10.1080\/0886022X.2020.1819318"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hihara K, Iyoda M, Tachibana S, et al. Anti-phospholipase A2 receptor (PLA2R) antibody and glomerular PLA2R expression in Japanese patients with membranous nephropathy. PLoS One 11: e0158154, 2016.","DOI":"10.1371\/journal.pone.0158154"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hoxha E, Thiele I, Zahner G, Panzer U, Harendza S, Stahl RA. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol 25: 1357-1366, 2014.","DOI":"10.1681\/ASN.2013040430"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Tomas NM, Beck LH Jr, Meyer-Schwesinger C, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 371: 2277-2287, 2014.","DOI":"10.1056\/NEJMoa1409354"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hoxha E, Beck LH Jr, Wiech T, et al. An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy. J Am Soc Nephrol 28: 520-531, 2017.","DOI":"10.1681\/ASN.2016010050"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Van de Logt AE, Hofstra JM, Wetzels JF. Serum anti-PLA2R antibodies can be initially absent in idiopathic membranous nephropathy: seroconversion after prolonged follow-up. Kidney Int 87: 1263-1264, 2015.","DOI":"10.1038\/ki.2015.34"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ramachandran R, Kumar V, Nada R, et al. Serial monitoring of anti-PLA2R in initial PLA2R-negative patients with primary membranous nephropathy. Kidney Int 88: 1198-1199, 2015.","DOI":"10.1038\/ki.2015.310"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sharma SG, Larsen CP. Tissue staining for THSD7A in glomeruli correlates with serum antibodies in primary membranous nephropathy: a clinicopathological study. Mod Pathol 31: 616-622, 2018.","DOI":"10.1038\/modpathol.2017.163"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/19\/60_6413-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:40:20Z","timestamp":1715143220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/19\/60_6413-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":19,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6413-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]},"article-number":"6413-20"}}